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Abstract
Background: Worldwide used pesticides containing different adjuvants like Roundup formulations, which are
glyphosate-based herbicides, can provoke some in vivo toxicity and in human cells. These pesticides
are commonly found in the environment, surface waters and as food residues of Roundup tolerant genetically
modified plants. In order to know their effects on cells from liver, a major detoxification organ, we
have studied their mechanism of action and possible protection by precise medicinal plant extracts
called Dig1.
Methods: The cytotoxicity pathways of four formulations of glyphosate-based herbicides were studied using
human hepatic cell lines HepG2 and Hep3B, known models to study xenobiotic effects. We monitored
mitochondrial succinate dehydrogenase activity and caspases 3/7 for cell mortality and protection by Dig1, as
well as cytochromes P450 1A1, 1A2, 3A4 and 2C9 and glutathione-S-transferase to approach the mechanism of
actions.
Results: All the four Roundup formulations provoke liver cell death, with adjuvants having stronger effects than
glyphosate alone. Hep3B are 3-5 times more sensitive over 48 h. Caspases 3/7 are greatly activated in HepG2 by
Roundup at non-cytotoxic levels, and some apoptosis induction by Roundup is possible together with necrosis.
CYP3A4 is specifically enhanced by Roundup at doses 400 times less than used in agriculture (2%). CYP1A2 is
increased to a lesser extent together with glutathione-S-transferase (GST) down-regulation. Dig 1, non cytotoxic
and not inducing caspases by itself, is able to prevent Roundup-induced cell death in a time-dependant manner
with an important efficiency of up to 89%, within 48 h. In addition, we evidenced that it prevents Caspases 3/7
activation and CYP3A4 enhancement, and not GST reduction, but in turn it slightly inhibited CYP2C9 when added
before Roundup.
Conclusion: Roundup is able to provoke intracellular disruption in hepatic cell lines at different levels, but a
mixture of medicinal plant extracts Dig1 can protect to some extent human cell lines against this pollutants. All
this system constitutes a tool for studying liver intoxication and detoxification.
Background
Roundup (R) is the most widely used non-selective herbi-
cide worldwide. It is comprised of a mixture of an isopro-
pylamine salt of glyphosate (G) and adjuvants. G is
considered as the active ingredient of R, although quantita-
tively it is a minor constituent, which is not supposed to be
toxic alone in mammals [1]. Various adjuvants are present
in R as secret of formulations [2], amplifying and thus
allowing the G herbicide action, as well as its unintended
toxic and endocrine disrupting effects in human placental
cells [3]. The adjuvants, which are chosen from a long list
that can vary from formulation to formulation [4], stabilize
and help G penetration into cells. Among these are benzi-
sothiazolone, isobutene, light aromatic petroleum distillate,
methyl pyrrolidinone, polyethoxylated tallowamine or alky-
lamine (POEA), etc [2]. Some of these compounds may be
genotoxic or form adducts with DNA [5]. It is thus impor-
tant to compare different R formulations when studying
* Correspondence: criigen@unicaen.fr
1Laboratory of Biochemistry EA2608, Institute of Biology, University of Caen,
France
Full list of author information is available at the end of the article
Gasnier et al. Journal of Occupational Medicine and Toxicology 2010, 5:29
http://www.occup-med.com/content/5/1/29
© 2010 Gasnier et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.this herbicide’s toxicity. Moreover R residues are quite
stable in rivers and soils [1]. G and its metabolite AMPA
(aminomethyl phosphonic acid) are among the primary
pollutants of surface waters (IFEN, 2006); they also enter
the food chain [6]. These chemicals are found in the urine
of agricultural workers [7]. The use of this herbicide is
increasing as more than 75% of genetically modified edible
plants have been designed to be used in conjunction with
R. These plants are engineered to tolerate high intracellular
levels of R [8]. We have also shown that the human
embryonic kidney 293 cell line was even more sensitive to
R, this was dose- and time-dependent [4]; and thus it was
hypothesized that this could explain pregnancy outcomes
and miscarriages reported for agricultural workers using
G-based herbicides [9]. This is consistent with the fact that
G-based herbicides have recently been shown to be endo-
crine disruptors in cell lines [10].
We know that xenobiotics have a main endpoint in
the liver, which is the major detoxification organ. Here,
we investigated the mechanism of action of R in the
human liver cell lines available, HepG2 and Hep3B,
which have been used as a model system to study xeno-
biotic toxicity, most prominently HepG2 [11,12]. We
wanted to compare in the first instance the actions of
four R formulations on both cell lines and then to detail
the enzymatic pathways activated in HepG2.
Detoxifying mechanisms are frequently enhanced by
plant extracts, which can provide additional protection
against radicals and electrophilic compounds [13,14].
We have tested the ability of a new drug described for
the first time, Dig1 (D), to protect cells from R intoxica-
tion. D contains plant extracts from Taraxacum offici-
nalis, Arctium lappa and Berberis vulgaris. These herbal
preparations were chosen in particular for their digestive
detoxification or hepato-protective effects [15-20]. It was
thus interesting to compare these general findings on
plant extracts to some biochemically precise markers
that could be modified in human hepatocytes, such as
caspases 3/7, cytochromes P450, glutathione S-transfer-
ase (GST), and mitochondrial succinate dehydrogenase
(SD), in order to detail the pathway(s) of action(s) of
these mixtures used as medicinal plants in vivo,a n d
thus to explore their cellular protective potential.
Methods
1. Chemicals
Four main R formulations which have been used in agri-
culture (Monsanto, Anvers, Belgium) have been chosen in
this study: Express® 7.2 g/l of G called glyphosate or N-
(phosphonomethyl) glycine, product number 2010321;
Bioforce® 360 g/l of G, product number 9800036; GT® 400
g/l of G, product number 8800425; GT+® 450 g/l of G,
product number 2020448. The various herbicide formula-
tions were prepared in Eagle’s modified minimum
essential medium (EMEM; Abcys, Paris, France), with 10%
calf fetal serum from Cambrex (Verviers, Belgium) other-
wise specified. G was from Sigma-Aldrich (Saint Quentin
Fallavier, France), its called “2% solution” was equivalent
in concentration to 2% R Bioforce® and was prepared in
serum free-medium, and adjusted to pH 5.8 of 2% R. D is
a mixture of diluted plant extracts obtained by Sevene
Pharma (Monoblet, France) from original independent
macerates corresponding to 1/10 of dried plants in a
water-alcohool solution of 45 to 55%. They are afterwards
diluted in 70% alcohol with Taraxacum officinalis mace-
rate at 10
-4, Arctium lappa at 10
-4 and Berberis vulgaris at
10
-5. D is prepared in the medium at 2% of the mixture
in positive controls. The 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) and all other
compounds, unless otherwise specified, were from Sigma-
Aldrich. The MTT stock solution at 5 mg/ml in phos-
phate-buffered saline was diluted 10-fold in serum-free
EMEM and then filtered through a 0.22 μm filter.
2. Cell cultures, Roundup and/or Dig1 exposures
The hepatoma cell lines HepG2 and Hep3B were pro-
vided by ECACC, numbers 85011430 and 86062703,
respectively. They are from Caucasian and Negroid hepa-
toma origins (from 15- and 8-year-old children respec-
tively). Cells were grown in flasks of 75 cm
2 surface from
Dutscher (Brumath, France) in phenol red-free EMEM
containing 2 mM glutamine, 1% non-essential amino
acid, 100 U/ml of antibiotics (mix of penicillin, strepto-
mycin) and 10% fetal calf serum. For treatments, 50,000
cells were plated per well and grown at 37°C (5% C02,
95% air) during a period of 48 h to 80% confluence in
48-well plates (except in Figure 1, 24-well plates were
used). The cells were then exposed (24-72 h) to various
concentrations of tested chemicals, which were replaced
every 24 h for D studies. D was at 2%. For cytochromes
and GST studies, before S9 fractions preparations, cells
were treated in 25 ml and in 175 cm
2 flasks at 80% con-
fluence. In this case after 24 h, another 25 ml was added
as the second treatment. In all cases, medium M
w a su s e da sc o n t r o la n dRw a sp r e s e n ta tt h eL C 5 0 ,
which was 25 ppm for R400 in these conditions,
far below doses recommended in agriculture (1-2%,
i.e. 10,000-20,000 ppm).
3. S9 fractions
The medium was removed, and cells dislodged by treat-
ment with 7 ml of trypsin-EDTA (Lonza, France) and
washed (PBS, Eurobio, France) twice by centrifugations
(70 g, 5 min), at room temperature. Cells were then resus-
pended in 500 μl of 50 mM phosphate buffer pH 7.5 with
0.25 M sucrose, 1 mM DTT, homogenized and centri-
fuged at 9,000 g, 4°C for 30 min. The supernatants corre-
sponding to the S9 fractions (membrane and cytosolic
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evaluation for enzyme activities. Protein concentration was
determined in each S9 fraction according to the Bicincho-
ninic Acid Protein Assay (Sigma, France).
4. Cell death measurement
The enzymatic MTT test is based on the cleavage of
MTT into blue formazan by the mitochondrial enzyme
succinate-dehydrogenase [21,22], it was used to evaluate
human cell viability as described in our group [23]. The
optical density was measured using a luminometer
(Mithras LB 940, Berthold, France) at 570 nm. The crude
protective actions were evaluated at the end of the treat-
ment, by comparing the toxicity of R after treatment by
D or not. As R toxicity is induced at the chosen LC50,
the relative efficiency of the protective effect (recovering)
is the percentage of recovered viability in the presence of
D in comparison to the maximal toxic effect at LC50.
5. Caspase 3/7 activity measurement
The Caspase-Glo® 3/7 assay (Promega, Paris, France) in
96-well white plates (Dutscher, France) was a luminescent
method designed for automated high-throughput screen-
ing of caspases activity, which is a measure of apoptosis.
This method can measure caspase-3 and -7 activities in
purified enzyme preparations or cultures of adherent or
suspended cells [24-26]. The assay provides a pro-lumines-
cent caspase-3/7 substrate, which contains the tetrapeptide
sequence DEVD. This substrate is cleaved to release
amino-luciferin, a substrate for luciferase, and the produc-
tion of light is proportional to the quantity of amino-luci-
ferin released and therefore proportional to caspase. The
Caspase-Glo® 3/7 reagent has been optimized for caspase
activity, luciferase activity and cell lysis. The addition of
the single Caspase-Glo® 3/7 reagent, in an “add-mix-
measure” format, results in cell lysis followed by caspase
cleavage of the substrate and generation of a “glow-type”
luminescent signal. After cell cultures were exposed to 50
μL of various dilutions, an equal volume of Caspase-Glo®
3/7 reagent was added to each well. Plates were then agi-
tated 15 min and incubated 45 min at room temperature
in the dark, to stabilize the signal before measuring lumi-
nescence. The negative control was the serum-free med-
ium, the positive control was the active Caspase-Glo® 3/7
Figure 1 Time-dependent effects of different Roundup formulations on HepG2 and Hep3B cell viability. The formulations were applied
during 24 h (A and C) or 48 h (B and D). These effects were evaluated by the MTT test (see Methods), measuring mitochondrial succinate
dehydrogenase activity. The results are presented in percent compared to non treated cells (M). Cells were grown at 37°C (5% C02, 95% air) in
medium EMEM with 10% serum during 48 h to 80% confluence in 24-well plates, and then exposed to 4 different Roundup formulations. On ×
axis, concentrations of G in R in parenthesis: Express® 7.2 g/l of G, Bioforce® 360 g/l of G, GT® 400 g/l of G, GT+® 450 g/l of G, all at 0.5%. All
experiments were repeated 3 times in triplicates. Statistically significant differences are calculated in comparison to control by a student t-test
p < 0.01(**) and p < 0.05(*).
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medium to determine the basal activity of the caspases 3/
7. Luminescence was measured using the luminometer
Mithras LB 940 (Berthold, Thoiry, France) at 565 nm.
6. Cytochrome P450 activity measurement
The cytochrome P450 3A4, 2C9, 1A2 and 1A1 activities
were quantified by the P450 Glo™ Assays (Promega,
France), as described by Yueh et al. [27]. Each Cyto-
chrome P450/1 M KPO4/Substrate Reaction mixture
containing the S9 fractions (duplicate) was pre-incu-
bated at 37°C for 10 min in white 96-well plates
(Dutscher, France). The Cytochrome P450 CYP1A1
Reaction mixture contained 135 μg of the human liver
S9 fraction as control (Tebu-Bio, France) or cell S9
fraction with 60 μM luciferin-conjugated substrate (luci-
ferin-6’-chloroethyl ether) and 200 mM KPO4 buffer in
a final volume of 25 μl. For CYP1A2 130 μg S9 fractions
were used with 200 μM substrate of luciferin-6’-methyl-
ether; for CYP2C9 160 μg S9 and 200 μMs u b s t r a t eo f
6’-deoxy luciferin but with 50 mM KPO4 buffer in 25 μl.
CYP3A4 was measured with 170 μgS 9w i t h1 0 0μM
substrate of luciferin-6’-benzylether but with 400 mM
KPO4 in 25 μl. The enzymatic reaction was initiated by
adding 25 μl of NADPH regenerating system to each
well. It contained 2.6 mM NADP
+,6 . 6m Mg l u c o s e - 6 -
phosphate, 0.8 U/ml glucose-6-phosphate dehydrogenase
and 6.6 mM MgCl2.
The plate was then incubated at 37°C for 20 min for
CYP1A1 and CYP1A2, and, for 30 min for CYP2C9 and
CYP3A4. The reconstituted Luciferin Detection reagent
(50 μl) was added before mixing for 10 s and incubating
at room temperature for 90 min in order to stabilize the
luminescent signal. The luminescence was then read
with a luminometer (Veritas Turner Biosystems). Three
independent experiments were carried out using three
independent batches of S9 fractions.
7. GST activity measurement
The protocol was adapted from Habig et al. [28]. Briefly,
320 μg( 5 0μl) of the human liver S9 fraction (positive
control) or cell S9 fraction was mixed with 10 μlo f1 0 0
mM GSH and 930 μl phosphate buffer in duplicate.
Reduced L-glutathione (GSH) was dissolved in deionized
water; pH 6.5 buffer was prepared by mixing 0.7 volume
of 0.1 M KH2PO4 and 0.3 volume of 0.1 M Na2HPO4.
The reaction was initiated by 10 μlo f1 0 0m M
1-chloro-2,4-dinitrobenzene (CDNB) substrate. The
CDNB was dissolved in 95% ethanol at a concentration
of 100 mM (20.3 mg/ml). After a 90 s incubation at 37°
C, the optical density was measured at 340 nm every
30 s for 90 s with a SmartSpec 3000 Spectrophotometer
(Bio-Rad, France). Three independent experiments were
carried out using three independent batches of S9
fraction.
8. Statistical analysis
The experiments were repeated 3 times in different
weeks in triplicate (n = 9) unless otherwise specified. All
data are presented as the mean ± standard error (S.E.
M.). Statistical differences were determined by a Student
unpaired t-test using significant levels of p < 0.01 (**)
and p < 0.05 (*).
Results
Figure 1 presents the different time-dependent effects of
various R formulations at 0.5% on viability of liver cell
lines HepG2 and Hep3B. The R formulations contained
different concentrations of both G and various adju-
vants. Both cell lines showed approximately similar
growth rates for around 32 h in control medium (M). In
both cell lines, growth rate was easily disrupted by any
R formulation, but different R formulations had different
effects. In the case of R7.2 and R360, Hep3B cells were
approximately 3-5 times more sensitive than HepG2
over 48 h. However, in the case of R400 and R450 at
0.5% the two cell lines were roughly equal in sensitivity.
These two R formulations were found to be most rapid-
acting and toxic. Based on this observation these were
chosen for use in subsequent experiments. Cell death
was estimated by inhibition of succinate-dehydrogenase
and thus of mitochondrial metabolism. In both cell
lines, mortality increases with G concentrations and
time of exposure to all 4 R formulations, however the
increase is not proportional to G concentration (insert
Figure 2). The first two formulations demonstrate simi-
lar toxicities despite having quite different concentra-
tions of G (7.2 and 360 g/l of G, respectively), along
with adjuvants; the two other formulations show higher
toxicity as previously explained. This dose-dependent
effect is clearly illustrated in Figure 2 with the two
groups of decreasing curves with the two families of R
(R400 and R450 on one side, first toxic family, and R7.2
and R360 on the other). It also becomes obvious that G
has no toxic action alone under the conditions used in
this study (empty squares, Figure 2).
We identified the LC50 of R400 (GT®) in 24 h in
48-well plates as being 40 ppm for Hep3B and 96 ppm
for HepG2. No difference was seen between HepG2 and
Hep3B cells in their sensitivity to R400 when exposed at
relatively high concentrations in Figure 1. Titrations to
determine the LC50 of R400 revealed clearly that Hep3B
cells were more sensitive to R400 than were HepG2. We
then tested the impact of 2% D at these conditions of R
intoxication (Figure 3). We confirmed R400 toxicity
to hepatocyte-derived cell lines exposed at the LC50 for
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First, we demonstrated that D alone was not toxic, at
2 %f o ra sl o n ga s7 2h ,n o rw a si ta b l et oi n h i b i tm i t o -
chondrial metabolism (data not shown). Then we
observed that pre-treatment with D (in comparison to
control M) had a time-amplified protective effect from
the most toxic R. After 24 h of D exposure and 24 h of
R, the efficiency of protective action of D reached 43%
for Hep3B, and 55% for HepG2. After 48 h of D and 24
h of R, the efficiency of D reached 62% and 89% respec-
tively. These effects were proportional to time (compare
curve DRM to RMM). No curative effect (positive D
action after R) was observed under these conditions
with these cells since post-treatment with D did not
influence R toxicity (curves are superimposed with
RMM, see Figure 3, legend).
The mechanism was studied in more detail in HepG2
where the enzymes are better characterized and
assessed. First, we evaluated the time-course for onset of
the preventive effect of D, by incubating cells with D
and removing it before R addition (Figure 4). We show
that the efficiency of protection of D is established (53%
in this case) at 24 h, but can be observed as early as 6 h
after adding D to cells. At this time, protection from the
toxicity of R was significant. We then investigated what
might be the metabolic target of the protective effect of
D. Caspases 3/7 are shown in Figure 5 to be activated
up to 156% by 24 h exposure to R and up to 765% by
48 h exposure (comparison was to the control M at 24
h and MM at 48 h). After 24 h of exposure, if R is
replaced by M, the caspases recover in 24 h to their
initial activity. Figure 5 shows that D does not induce
caspases itself, but appears to prevent induction of cas-
pases by R (DR). Considering caspases activities as an
early sign of apoptosis, these results confirm lack of D
toxicity and the ability of D to protect from R toxicity.
In addition to caspases, we examined the effects of R
on cytochromes, finding that R does not activate all
cytochromes but is able to enhance more specifically
CYP3A4 (to 240-360%) and to a lesser extent CYP1A2
(to 130-170%, Figure 6). D does not enhance these cyto-
chromes by itself (RD versus RM, Figure 6); but it
weakly increases CYP2C9 in combination with R (to
140%), when added after it, even though this is not sta-
tistically different from RM treatment (but from control
M alone). Once again, based on this additional para-
meter, D confirmed its ability to block R toxicity: if D is
applied before R no cytochrome activity was stimulated,
CYP2C9 was even weakly inhibited (40%). By contrast,
in Figure 7, it is shown that R inhibits GST almost by
half, and D does not modify this effect either before or
after R treatment. Figure 8 summarizes the results
obtained on the different pathways of R and D actions
on HepG2.
Figure 2 Dose-dependent effects of Glyphosate and different Roundup formulations on HepG2 viability. The formulations were applied
during 24 h without serum (even for G) in 48-well plates, after reaching 80% confluence with serum-containing medium. These effects and the
formulations with G concentrations (7.2 to 450 g/l) indicated with symbols were evaluated as described in Fig. 1. All experiments were repeated
4 times in triplicates. The curve in frame summarizes the nonlinear dose effects of R formulations on HepG2. The LC50 (%) values are compared
for the 4 R and G (in similar conditions) as a function of G concentrations in the formulations. The LC50 for G alone is indicated by the empty
square above the curve.
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This work evidences for the first time the effects of sev-
eral formulations of the major herbicide worldwide (R)
on human hepatic cell lines available, which are widely
recognized as models to study xenobiotic actions. We
tested R at sub-agricultural levels; the LC50 measured in
this work is 10 times for Hep3B and 4 times for HepG2
below the maximum level of residues authorized in
some feed (400 ppm, [29]). We found that the cell sensi-
tivity depended on the nature of the R formulation. Both
cell lines have retained the activities of the drug metabo-
lism phase I and phase II enzymes involved in activation
and detoxification of genotoxic carcinogens [30,31].
HepG2 cells are in general considered a better model
since they have three-fold higher levels of CYP1A1 and
glutathione-S-transferase (GST) than Hep3B [32]. For
Figure 3 Dig1 general preventive effect of R400 toxicity on Hep3B and HepG2 during 72 h. In frames on the right, each letter (M, R or D)
indicates 24 h of successive cell exposures to the corresponding conditions (Medium alone, Roundup, Dig1). The results were evaluated as in
Fig. (1). To measure preventive effects, D at 2% was applied during 24 or 48 h before R (400 g/l at LC50 in these conditions, 40 ppm for Hep3B
and 96 ppm for HepG2): corresponding treatments called DRM or DDR. R was applied alone as negative control during 24 or 72 h (RMM, RRR),
or before D to assess curative effects (RDM, RMD or RDD), all these curves are superimposed, and thus only RMM is shown as negative control.
No curative effect is evidenced in these conditions. Efficiencies of protection (EP) after 24 or 48 h of treatment by D are indicated in frames.
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than Hep3B to cisplatin [33], to dietary genotoxins [32]
and to genotoxicants [12]. In our hands it was the oppo-
site for R, overall in 48 h. In fact, both cell lines are
from different genetic origins, from different boys at
different ages, and thus have specific enzymatic equip-
ments including cytochromes P450. Greater sensitivity
was observed with Hep3B. It was thus important to
obtain results in both lines that confirmed R toxicity in
all human models tested up to now, including
Figure 4 Time necessary for Dig1 pre-incubation to achieve a significant preventive effect of subsequent R intoxication. The study is
performed with R400 intoxication on HepG2, cell viability is measured as in Fig. (1). First D (2% - dotted line with squares) was applied (time on
× axis) 15, 30 min, 1 to 24 h before R400 (96 ppm during 24 h - grey line with triangles), in comparison to M (black line with diamonds). More
than 40% viability (R effect in these conditions) is obtained only after at least 6 h of D exposure (increasing dotted line).
Figure 5 Roundup and Dig1 on HepG2 caspase 3/7 activity. These effects were evaluated by the caspases Glo® 3/7 assay, the results are
presented in percent compared to untreated cells (M). Cells were grown at 37°C (5% C02, 95% air) in serum containing medium during 48 h to
80% confluence in 96-well plates, and then exposed to different treatments (R450: 60 ppm, D 2%) without serum. The formulation was applied
during 24 h (M, D, R) or 48 h (MM to DR).
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derived JEG3 cells and microsomes from fresh placenta
[3,4,34]. It was evidenced that cell death increased with
time of exposure for all R formulations, this phenom-
enon shows that the threshold of toxicity depends not
only on the dose but also on time, as previously clearly
demonstrated on embryonic and placental cells [4]. It
was also shown that toxicity was dependent on the nat-
ure of the adjuvants present in different R formulations.
Moreover, the action of serum only temporarily buffered
R toxicity. We found that serum-free culture medium
revealed essentially the same xenobiotic impacts that are
visible 1-2 days later in serum. Thus, although the time-
course of action is delayed, the pathways of actions
appear similar [4].
Indeed, the G cytotoxic effects do not vary linearly
with dose; this demonstrates the differential roles of
adjuvants in the amplification of toxicity, since G has no
Figure 6 Roundup and Dig1 on HepG2 Cytochromes P450 activities. These effects were evaluated by the P450 Glo® assay, the results are
presented as percent relative to control (MM). Cells were treated before S9 fractions preparations in 25 ml and in 175 cm
2-flasks at 80%
confluence. After 24 h of M, R (LC50 of R400, 25 ppm in these conditions) or D (2%), another 25 ml was added as the second treatment.
Figure 7 Roundup and Dig1 on HepG2 glutathione-S-transferase activity. The results are presented in percent compared to untreated cells
(MM). Cells were treated before S9 fractions preparations in 25 ml and in 175 cm
2-flasks at 80% confluence. After 24 h of M, R (LC50 of R400, 25
ppm in these conditions) or D (2%), another 25 ml was added as the second treatment.
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added to G in various R formulations are considered
manufacturing secrets, but obviously do not form an
inert part of the composition. One mechanism of adju-
vant action is most probably to form detergent vesicles
that allow cell membrane opening and penetration of G,
and that most probably facilitate bioaccumulation of G,
metabolites and adjuvants, and gene disruptive effects,
which could explain time-amplified effects. A very small
quantity of adjuvants combined with G has been already
demonstrated to have similar effects to R [3]. It is a
recognized fact that mixtures of xenobiotics have syner-
gistic effects [35]. We observed that whatever the nature
of the various adjuvants is in the 4 R formulations, the
mechanism of toxicity is similar on several crucial end-
p o i n t s :n a m e l yS D ,A K ,C a s p a s e s3 / 7[ 3 4 ] .O n l yt h e
threshold of toxicity is different.
In this study, we sought to understand the mechanism
of toxicity of the two R formulations that have the most
rapid toxic effects on hepatic cells. We also evaluated
w h e t h e ri tw a sp o s s i b l et op r e v e n tRt o x i c i t yb yD .Di s
a newly described product comprised of a mixture of
extracts from Taraxacum officinalis, Arctium lappa and
Berberis vulgaris. Taraxacum was cited for protective
effects in the digestive system [19,20], also anti-tumoral
[36] and anti-oxydant effects [37]. Arctium lappa is also
found to be hepato-protective [17,18], as well as Berberis
[16].
First of all, the lack of D impact on cell viability in
comparison to controls indicates that it is not cytotoxic
at 2%. It was hypothesized first that either D does not
penetrate cells without embedding cell-cell interactions,
or it is relatively inert on several important markers of
cell function at this concentration. Our results are con-
sistent with D penetrating the cells and not just forming
a shield that prevents R from penetrating. This is veri-
fied since effective protection by D necessitates more
than 6 h of contact, and because D modifies enzymatic
Figure 8 Roundup (R) mechanisms of action and prevention by Dig1 (D) in human hepatocytes HepG2. The different pathways of action
identified in this research are summarized with black arrows: action via on mitochondrial succinate dehydrogenase, and action via caspases 3/7
inducing cell death (directly or indirectly through cytochrome C, and possibly via death cell receptors), action via cytochromes CYP3A4 and
CYP1A2 stimulating the formation of metabolites, and finally action via the inhibition of Glutathione-S-transferase (GST) blocking metabolites
derivatization and excretion. D does not act itself at these levels (crossed empty arrows) but prevents R toxicity (black thick lines).
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Page 10 of 13activities, as detailed below. As a matter of fact, D shows
a clear and very strong efficiency of protective action
against the toxicity of R in both hepatic cell lines; pro-
tection is up to 89% for HepG2 in 48 h. It is not com-
pletely excluded that this important action of D can
occur by preventing entrance of R into cells, normally
helped by adjuvants. However D clearly has intracellular
actions, including prevention of caspases 3/7 activation
and CYP3A4 enhancement, both provoked by R. CYP
3A4 was induced by Roundup in comparative manner
and in similar time than with other xenobiotics Bisphe-
nol A, DDT and phtalates, respectively [38-40].
Other metabolic/biochemical effects of D components
have also been reported, for instance, the protective
effects on acute pancreatitis in rats [20] through IL-6
reduction, as well as the suppression of reactive oxygen
species, nitric oxide and lipid oxidation [37]. Polypheno-
lic compounds present in D are considered hepatopro-
tective [42-44] but the time-dependent protective effects
on the crucial mitochondrial succinate dehydrogenase
and caspases 3 and 7 had not been demonstrated before.
Since HepG2 are more resistant and D more preven-
tive on this line, we decided to detail the signalling
pathway of R and D actions in these cells. Moreover,
the caspases, cytochromes and GST activities are more
fully documented in this hepatic cell line [45-47]. The
measurement of caspase 3/7 activity has been recog-
nized as a marker for apoptosis in HepG2 cells [48].
Caspases 3/7 have been rarely measured in HepG2,
and found to be induced 200% by 30 μM Tamoxifen in
24 h [48]. Their induction by R in our study (156% in
24 h and 765% in 48 h) confirms the proposed apoptotic
mechanism activated by R. Of course, this does not
e x c l u d es o m en e c r o s i sa sap r i m a r ym o d eo fc e l ld e a t h
as we previously showed [34]. Our results also show
that D alone does not interfere with caspases but may
possibly prevent R impact on these enzymes.
At lower levels and even with the buffering effect of
serum already documented [4], D also prevents CYP3A4
induction: CYP3A4 is by far the major target of R
among the phase I activating enzymes measured.
CYP3A4 is the most abundant P450 expressed (60%) in
human liver [49]. It is involved in the bioactivation of
environmental procarcinogens, such as aflatoxin B1 [50]
and benzo[a]pyrene among a number of others [51].
Some organochlorine pesticides can activate the PXR, a
nuclear hormone receptor [52] that regulates CYP3A4
gene transcription in particular in liver. R components
may also induce this process. The results with CYP1A2
(slight induction by R) show that its action does not
depend on a unique pathway, like the results on
C Y P 2 C 9 .O n l yaf e wr e p o r t sa r ea v a i l a b l eo nC Y P 2 C 9 ,
which is inhibited by extracts of other plants such as
pineapple [53].
Similarly, only some xenobiotics such as polychloroby-
phenyls inhibit GST; this is typical of estrogen-like
effects [54] already observed with R on aromatase [3,4].
The disruption of xenobiotic metabolism by R in our
study, which increased some cytochromes P450 and
decreased GST, may alter liver detoxification function,
leading to the accumulation of toxic reactive oxydated
molecules [54] in a manner that could be prevented by
D in this study. In fact, GST inhibition, if R intoxication
continues, could lead to the accumulation of reactive
compounds, due to disruption of xenobiotic excretion.
In conclusion, it is demonstrated and explained that
high hepatic cell line mortality is provoked by R, at doses
far below those used in agriculture. The mechanism
of action on various essential enzymes is detailed in
Figure 8. This impact on cell death was observed at doses
far smaller than legally allowed residues of G in GM food
or feed (400 ppm, [29]), in our study LC50 was in com-
parison 40 to 96 ppm. Of course G can be metabolized
and excreted out of the body but this has to be balanced
in regard to its cell penetration and bioaccumulation due
to adjuvants. In these conditions, this can be almost
t o t a l l yp r e v e n t e di nH e p G 2i n4 8hb yas p e c i f i cd r u g ,D ,
that mostly prevents caspases 3/7 activation and CYP3A4
enhancement, both provoked by R. However it does not
prevent GST inhibition by R that could lead to accumula-
tion of toxic reactive compounds. Since the use of cell
lines allows longer experiments, and since cell lines may
in some instances be less sensitive to xenobiotics than
primary cultures [55], this system with R and Dig1 con-
stitutes an interesting tool for studying liver intoxication
and detoxification. The activity of Dig1 should be now
also tested in vivo in animal experiments.
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